A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients.

Autor: Mehtap Ö; Department of Hematology, Kocaeli University, Kocaeli, Turkiye., Toptas T; Department of Hematology, Marmara University, Istanbul, Turkiye., Dal MS; Department of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkiye., Karadag FK; Department of Hematology, Ege University, Izmir, Turkiye., Atas U; Department of Hematology, Akdeniz University, Antalya, Turkiye., Özsan GH; Department of Hematology, Dokuz Eylul University, Izmir, Turkiye., Sayınalp N; Department of Hematology, Hacettepe University, Ankara, Turkiye., Saydam G; Department of Hematology, Ege University, Izmir, Turkiye., Uçar MA; Department of Hematology, Cukurova University, Adana, Turkiye., Kırkızlar HO; School of Medicine, Republic of Türkiye Trakya University, Edirne, Turkiye., Salim O; Department of Hematology, Akdeniz University, Antalya, Turkiye., Tekinalp A; Department of Hematology, Necmettin Erbakan University Meram, Konya, Turkiye., Özkalemkaş F; Department of Hematology, Bursa Uludağ University, Bursa, Turkiye., Pepedi F; Department of Hematology, Cukurova University, Adana, Turkiye., Akay OM; Department of Hematology, Koç Universityİstanbul, Turkiye., Kılıçaslan E; Department of Hematology, Gülhane Training and Research Hospital, İstanbul, Turkiye., Paydas S; Department of Hematology, Cukurova University, Adana, Turkiye., Bozdağ SC; Department of Hematology, Koç Universityİstanbul, Turkiye., Yılmaz M; Department of Hematology, SANKO University, Gaziantep, Turkiye., Karakus V; Department of Hematology, Antalya Education and Research Hospital, Antalya, Turkiye., Arikan FG; Department of Hematology, Marmara University, Istanbul, Turkiye., Darçın T; Department of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkiye., Erdogan E; Department of Hematology, Dokuz Eylul University, Izmir, Turkiye., Cinar E; Department of Hematology, Hacettepe University, Ankara, Turkiye., Gürsoy V; Department of Hematology, Bursa Uludağ University, Bursa, Turkiye., Durusoy SS; Department of Hematology, SANKO University, Gaziantep, Turkiye., Birtaş Ateşoğlu E; Department of Hematology, Yeditepe University, İstanbul, Turkiye., Tombak A; Department of Hematology, Mersin University, Mersin, Turkiye., Büyükkurt N; Department of Hematology, Baskent University Hospital Adana, Adana, Turkiye., Özcan M; Department of Hematology, Ankara University, Ankara, Turkiye., Altuntaş F; Department of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkiye., Kaygusuz Atagündüz I; Department of Hematology, Marmara University, Istanbul, Turkiye., Ferhanoglu B; Department of Hematology, Koç Universityİstanbul, Turkiye.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep 13, pp. 1-9. Date of Electronic Publication: 2024 Sep 13.

Is an earlier strategy for harvesting peripheral blood stem cells in healthy allogeneic donors feasible?

Autor: Yaman S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey. Electronic address: drsametyaman@gmail.com., Bozan E; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Seçilmiş S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Candır BA; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Kılınç A; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Başcı S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Yiğenoğlu TN; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Çakar MK; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Dal MS; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Altuntaş F; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey.

Publikováno v: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2024 Aug; Vol. 63 (4), pp. 103956. Date of Electronic Publication: 2024 May 27.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An effective treatment in Erdheim Chester disease: vemurafenib: a case report.

Autor: Bozan E; Department of Hematology and Bone Marrow Transplantation Center, Hematology and Bone Marrow Transplantation Unit, Health Sciences University Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey. ersinbozan87@gmail.com., Darçın T; Department of Hematology and Bone Marrow Transplantation Center, Hematology and Bone Marrow Transplantation Unit, Health Sciences University Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Yaman S; Department of Hematology and Bone Marrow Transplantation Center, Hematology and Bone Marrow Transplantation Unit, Health Sciences University Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Yiğenoğlu TN; Department of Hematology and Bone Marrow Transplantation Center, Hematology and Bone Marrow Transplantation Unit, Health Sciences University Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Kızıl Çakar M; Department of Hematology and Bone Marrow Transplantation Center, Hematology and Bone Marrow Transplantation Unit, Health Sciences University Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Dal MS; Department of Hematology and Bone Marrow Transplantation Center, Hematology and Bone Marrow Transplantation Unit, Health Sciences University Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey., Altuntaş F; Department of Hematology and Bone Marrow Transplantation Center, Hematology and Bone Marrow Transplantation Unit, Health Sciences University Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.

Publikováno v: Journal of medical case reports [J Med Case Rep] 2023 Oct 12; Vol. 17 (1), pp. 426. Date of Electronic Publication: 2023 Oct 12.